Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
An emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for patients. More
Astex uses a fragment-based approach to discover and develop small molecule molecularly targeted drugs for the treatment of cancer and other human diseases with significant unmet medical need. More
LIBBS is now searching for new in-licensing or co-marketing opportunities for the territory of Brazil in key areas like Cardiology, CNS, HRT, Contraception, GI, Dermatology, Respiratory and Oncology. More
The Italian National Institute of Health (ISS) is the main technical-scientific organ of the Ministry of health and the highest public healthcare research entity in Italy. More
Experts in Chemistry, Pharmacy and Analytical aspects of drug development. More
NPS Pharmaceuticals is engaged in the discovery, development, and commercialization of therapeutic small molecules and recombinant proteins to treat bone, gastrointestinal, and CNS disorders More
TopoTarget is a publically quoted biopharmaceutical company focused on the discovery and development of mechanism-based drugs for cancer. More
LBN was established in June 2000, providing the first co-ordinated approach to biotechnology in London. With over 2000 members, LBN is now one of the largest biotechnology networks in Europe. More
Probiodrug develops low-molecular weight organic molecules that modulate the activity of certain proteins as potential drugs. More
Medical School - Teaching Hospital - Research Institution More
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us